{"mainPropery":{"diseaseId":5984,"diseaseName":"Canavan disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5984/canavan-disease","synonyms":["Canavan-van Bogaert-Bertrand disease","Spongy degeneration of the central nervous system","Von Bogaert-Bertrand disease","Aspartoacylase deficiency","ASPA deficiency","ASP deficiency","ACY2 deficiency","Aminoacylase 2 deficiency"],"synonyms-with-source":[{"name":"Canavan-van Bogaert-Bertrand disease"},{"name":"Spongy degeneration of the central nervous system"},{"name":"Von Bogaert-Bertrand disease"},{"name":"Aspartoacylase deficiency"},{"name":"ASPA deficiency"},{"name":"ASP deficiency"},{"name":"ACY2 deficiency"},{"name":"Aminoacylase 2 deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"271900"},{"identifierType":"ORPHANET","identifierId":"141"},{"identifierType":"UMLS","identifierId":"C0206307"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"}],"organizations":[{"resourceID":32,"resourceName":"Jewish Genetic Disease Consortium (JGDC)","abbreviation":"","address1":"450 West End Ave., 6A","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10024","country":"United States","phone":"855-642-6900","tty":"","tollFree":"866-370-GENE (4363)","fax":"212-873-7892","email":"info@jewishgeneticdiseases.org","url":"http://www.JewishGeneticDiseases.org","freeText":""},{"resourceID":292,"resourceName":"Canavan Foundation","abbreviation":"","address1":"450 West End Avenue, #6A","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10024","country":"United States","phone":"212-873-4640 ","tty":"","tollFree":"877-4-CANAVAN ","fax":"212-873-7892","email":"info@canavanfoundation.org","url":"http://www.canavanfoundation.org","freeText":""},{"resourceID":293,"resourceName":"Canavan Research Foundation","abbreviation":"","address1":"88 Route 37","address2":"","address3":"","address4":"","address5":"","city":"New Fairfield","state":"CT","zip":"06812 ","country":"United States","phone":"203-746-2436 ","tty":"","tollFree":"","fax":"203-746-3205","email":"info@canavan.org","url":"http://www.canavan.org","freeText":""},{"resourceID":294,"resourceName":"Canavan Research Illinois","address1":"PO Box 8194","address2":"","address3":"","address4":"","address5":"","city":"Rolling Meadows","state":"IL","zip":"60008-8194 ","country":"United States","phone":"","tty":"","tollFree":"800-833-2194","fax":"","email":"info@canavanresearch.org","url":"http://www.canavanresearch.org"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/271900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=canavan+disease' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Canavan disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Canavan+disease%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Canavan disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=canavandisease' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Canavan disease. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0206307/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/157/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001586.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Canavan-Disease-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022130' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=141' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1234/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects_Simple.php?lng=EN&LnkId=8&Typ=Pat&fdp=y&from=rightMenu' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=8&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:271900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2286,"resourceId":3527,"resourceName":"Canavan Disease Patient Insight Network","descriptionText":"The <a href=\"https://connect.patientcrossroads.org/?org=Canavan\">Canavan Disease Patient Insight Network</a> (PIN) is a shared network that collects experiences directly from patients and families. PIN serves to create a research-ready community that can help drug developers and researchers get closer to finding targeted treatments and a cure.","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2328,"questionText":"What is Canavan disease?","answerText":"<strong>Canavan disease</strong> is a progressive, fatal, genetic disorder affecting the central nervous system, muscles, and eyes. Early symptoms in infancy may include increased head size, weakness, low muscle tone and loss of head control. Symptoms progress to seizures, blindness, inability to move voluntarily and difficulty eating solids or swallowing liquids. This condition&nbsp;is caused by changes in the <em><a href=\"https://ghr.nlm.nih.gov/gene/ASPA\" target=\"_blank\">ASPA</a></em> gene and is inherited in an autosomal recessive pattern. Canavan disease is diagnosed based on symptoms, laboratory testing, and genetic testing. There is no specific treatment. Treatment is focused on managing symptoms.[15471][15472][15475][1444]<br />","dateModified":"2020-04-14T00:00:00"},"basicQuestions":[{"questionId":2329,"questionText":"What are the signs and symptoms of Canavan disease?","answerText":"The following list includes the most common signs and symptoms in people with Canavan disease (CD). These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list also does not include every symptom or feature that has been described in Canavan disease.[1444][15472][15475]<br />\r\n<ul>\r\n    <li>Damage to the optic nerve (<a href=\"https://medlineplus.gov/ency/article/001622.htm\" target=\"_blank\">Optic atrophy</a>)</li>\r\n    <li>Blindness</li>\r\n    <li>Deafness (Hearing loss)</li>\r\n    <li>Increased head size (<a href=\"https://medlineplus.gov/ency/article/003305.htm\" target=\"_blank\">macrocephaly</a>)</li>\r\n    <li>Intellectual disability and&nbsp;developmental delay</li>\r\n    <li>Low muscle tone (<a href=\"https://medlineplus.gov/ency/article/003298.htm\" target=\"_blank\">hypotonia</a>)</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/001134.htm\" target=\"_blank\">Gastroesophageal reflux</a></li>\r\n    <li>Feeding difficulties in infancy</li>\r\n    <li>Inability to straighten joints (Flexion contractures)</li>\r\n    <li>Difficulty holding up head when pulled into a seated position (Head lag)</li>\r\n    <li>Abnormal growth of white matter in the brain (<a href=\"https://medlineplus.gov/leukodystrophies.html\" target=\"_blank\">leukodystrophy</a>)</li>\r\n    <li>Sleep disturbances\r\n    </li>\r\n</ul>\r\nInfants with Canavan disease appear normal at birth and usually develop symptoms between two and six months of age. These include low muscle tone, poor head control, an increased head size, and poor motor development. Later symptoms include optic nerve damage, blindness, and seizures. Over time, stiffening of arms and legs combined with low muscle tone, lead to an inability to move and swallow voluntarily.[15475][1444]<br />\r\n<br />","dateModified":"2020-04-14T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1444,"authors":"Matalon R, Delgado L, Michals-Matalon K","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 13, 2018","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1234/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15472,"authors":"Hoshino H, Kubota M","articleTitle":"Canavan disease: clinical features and recent advances in research","bookWebsiteJournalTitle":"Pediatr Int","date":"Aug 2014","volume":"56(4)","pages":"477-83","url":"https://www.ncbi.nlm.nih.gov/pubmed/24977939","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15475,"authors":"Bokhari MR, Samanta D, Bokhari SRA","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"StatPearls","date":"Updated Feb 21, 2020","volume":"","pages":"","url":"www.ncbi.nlm.nih.gov/books/NBK430816","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2330,"questionText":"What causes Canavan disease?","answerText":"Canavan disease is caused by genetic alterations in the&nbsp;<a href=\"http://ghr.nlm.nih.gov/gene=aspa\" title=\"A S P A\" class=\"link-dapple\" target=\"_blank\"><span><em>ASPA</em></span></a> gene.[15472][1444]<br />","dateModified":"2020-04-14T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1444,"authors":"Matalon R, Delgado L, Michals-Matalon K","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 13, 2018","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1234/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15472,"authors":"Hoshino H, Kubota M","articleTitle":"Canavan disease: clinical features and recent advances in research","bookWebsiteJournalTitle":"Pediatr Int","date":"Aug 2014","volume":"56(4)","pages":"477-83","url":"https://www.ncbi.nlm.nih.gov/pubmed/24977939","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2331,"questionText":"How is Canavan disease inherited?","answerText":"Canavan disease is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[1444] All individuals inherit two copies of each gene. Autosomal means the gene is found on one of the numbered chromosomes found in both sexes. Recessive means that both copies of the responsible gene must be altered to have the condition.<br />\r\n<br />\r\nPeople with autosomal recessive conditions inherit one alteration from each of their parents. The parents, who each have one gene alteration, are known as carriers.&nbsp; Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When two carriers of an autosomal recessive condition have children, there is a 25% (1 in 4) chance to have a child with the condition.<br />","dateModified":"2020-04-14T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1444,"authors":"Matalon R, Delgado L, Michals-Matalon K","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 13, 2018","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1234/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13371,"questionText":"How is Canavan disease diagnosed?","answerText":"Canavan disease is diagnosed based on the symptoms, laboratory results showing elevated levels of N-acetylaspartic acid (NAA) in urine, and genetic testing confirming genetic changes in the <em><a href=\"https://ghr.nlm.nih.gov/gene/ASPA\" target=\"_blank\">ASPA</a></em> gene.[15472][1444]<br />","dateModified":"2020-04-14T14:38:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":1444,"authors":"Matalon R, Delgado L, Michals-Matalon K","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 13, 2018","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1234/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15472,"authors":"Hoshino H, Kubota M","articleTitle":"Canavan disease: clinical features and recent advances in research","bookWebsiteJournalTitle":"Pediatr Int","date":"Aug 2014","volume":"56(4)","pages":"477-83","url":"https://www.ncbi.nlm.nih.gov/pubmed/24977939","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2332,"questionText":"How might Canavan disease be treated?","answerText":"There is no specific treatment for Canavan disease. Treatment is aimed at preventing and/or managing the known symptoms and complications associated with this condition. This may include seizure medication, physical and other therapies, and maintenance of food and water intake.[15471][15472][1444]<br />\r\n<br />\r\nSpecialists who might be involved the care of someone with Canavan disease include:\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/lab-tests/neurological-exam/\" target=\"_blank\">Neurologist</a></li>\r\n    <li>Ophthalmologist (eye doctor)</li>\r\n    <li>Genetics specialist (genetic counselor and/or geneticist)</li>\r\n    <li><a href=\"http://www.apta.org/\" target=\"_blank\">Physical therapist</a></li>\r\n    <li><a href=\"http://s3.gi.org/patients/ccrk/WhatIsAGastro.pdf\" target=\"_blank\">Gastroenterologist</a>\r\n    </li>\r\n</ul>","dateModified":"2020-04-14T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1444,"authors":"Matalon R, Delgado L, Michals-Matalon K","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 13, 2018","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1234/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15471,"authors":"Roscoe RB, Elliott C, Zarros A, Baillie GS","articleTitle":"Non-genetic therapeutic approaches to Canavan disease.","bookWebsiteJournalTitle":"J Neurol Sci","date":"Jul 15, 2016","volume":"366","pages":"116-124","url":"https://www.ncbi.nlm.nih.gov/pubmed/27288788","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15472,"authors":"Hoshino H, Kubota M","articleTitle":"Canavan disease: clinical features and recent advances in research","bookWebsiteJournalTitle":"Pediatr Int","date":"Aug 2014","volume":"56(4)","pages":"477-83","url":"https://www.ncbi.nlm.nih.gov/pubmed/24977939","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":15471,"authors":"Roscoe RB, Elliott C, Zarros A, Baillie GS","articleTitle":"Non-genetic therapeutic approaches to Canavan disease.","bookWebsiteJournalTitle":"J Neurol Sci","date":"Jul 15, 2016","volume":"366","pages":"116-124","url":"https://www.ncbi.nlm.nih.gov/pubmed/27288788","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15472,"authors":"Hoshino H, Kubota M","articleTitle":"Canavan disease: clinical features and recent advances in research","bookWebsiteJournalTitle":"Pediatr Int","date":"Aug 2014","volume":"56(4)","pages":"477-83","url":"https://www.ncbi.nlm.nih.gov/pubmed/24977939","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15473,"authors":"Kronn D, Oddoux C, Phillips J, Ostrer H","articleTitle":"Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population.","bookWebsiteJournalTitle":"Am J Hum Genet","date":"1995","volume":"57(5)","pages":"1250-1252","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801394/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15474,"authors":"Feigenbaum A, Moore R, Clarke J, et al","articleTitle":"Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay.","bookWebsiteJournalTitle":"AM J Med Genet A","date":"2004","volume":"124A","pages":"142-147","url":"https://www.ncbi.nlm.nih.gov/pubmed/14699612","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15475,"authors":"Bokhari MR, Samanta D, Bokhari SRA","articleTitle":"Canavan Disease","bookWebsiteJournalTitle":"StatPearls","date":"Updated Feb 21, 2020","volume":"","pages":"","url":"www.ncbi.nlm.nih.gov/books/NBK430816","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":6895,"relatedDiseaseName":"Leukodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10330,"phenoTypeName":"Reduced consciousness/confusion","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10117,"phenoTypeName":"Abnormality of visual evoked potentials","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13410,"phenoTypeName":"Gastroesophageal reflux","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8734,"phenoTypeName":"Hypertonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10564,"phenoTypeName":"Abnormality of retinal pigmentation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8859,"phenoTypeName":"Aplasia/Hypoplasia involving the central nervous system","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":2466,"phenoTypeName":"Brain atrophy","percentRanges":"-"},{"phenoTypeId":13657,"phenoTypeName":"CNS demyelination","percentRanges":"-"},{"phenoTypeId":4062,"phenoTypeName":"Delayed closure of the anterior fontanelle","percentRanges":"-"},{"phenoTypeId":8825,"phenoTypeName":"Elevated urinary N-acetylaspartic acid level","percentRanges":"-"},{"phenoTypeId":13869,"phenoTypeName":"Generalized-onset seizure","percentRanges":"-"},{"phenoTypeId":8826,"phenoTypeName":"Increased circulating N-Acetylaspartic acid concentration","percentRanges":"-"},{"phenoTypeId":8813,"phenoTypeName":"Increased CSF N-Acetylaspartic acid concentration","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":13846,"phenoTypeName":"Opisthotonus","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Canavan_disease"}